z-logo
open-access-imgOpen Access
Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: a sequential, randomized, double-blind clinical trial
Publication year - 2008
Publication title -
ožirenie i metabolizm
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.154
H-Index - 5
eISSN - 2306-5524
pISSN - 2071-8713
DOI - 10.14341/2071-8713-5236
Subject(s) - moxonidine , irbesartan , type 2 diabetes mellitus , medicine , double blind , randomized controlled trial , diabetes mellitus , clinical trial , type 2 diabetes , pharmacology , blood pressure , endocrinology , placebo , receptor , alternative medicine , pathology , agonist

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here